SCM appoints non-executive director

Adam Sims will play a major advisory role in CMO’s expansion plans

SCM Pharma, a UK-based sterile filling specialist, has hired a non-executive director as it bolsters its senior team to support its strategic development.

Adam Sims joins SCM Pharma’s board, bringing with him 20 years’ experience in the global pharmaceutical and chemical sector.

This is the latest top-level appointment at SCM Pharma. Graham Dotchin, commercial director and Neal Wesley, technical director have also joined the firm in the past 12 months.

Having spent seven years at Aesica in senior commercial and finance roles, Sims will play a major advisory role in SCM Pharma’s ongoing expansion plans. He said: ‘I am looking forward to supporting the executive team with my industry contacts, experience and knowledge to help ensure it continues to maintain its high profile, thrive as an independent business and achieve its commercial objectives.’

Dianne Sharp, managing director at SCM Pharma, said: ‘It’s certainly been a positive period for the company in terms of new projects and ongoing recruitment, but we’re not the type to rest on our laurels so are very much strengthening and looking at making our exciting future plans a reality.’

You may also like

Manufacturing

Shire buys assets of SCM Pharma

Confirms that 80 jobs are safeguarded at Northumberland-based company
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

HAPI capacity reaches an all-time high

While today’s drugs are more targeted and effective, they bring with them production issues of sterility and higher potency. Susan Birks reports on how the contract manufacturing market has responded to the growing demand for specialist high potency and sterile services
You need to be a subscriber to read this article.
Click here to find out more.
Containment

Handle with care – high potency APIs

Contract manufacturer SCM Pharma, which handles small volume runs of cytotoxic powders and liquids for several clients, outlines the basic containment and cleaning requirements for ensuring worker safety and product purity
Manufacturing

SCM\'s Prudhoe facility gains FDA approval

UK CDMO supports BTG for commercial launch of varicose veins treatment
Manufacturing

SCM Pharma gains MHRA approval for commercial facility

The site will be used for the supply of licensed commercial products and to complement its clinical manufacturing facility
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

The changing landscape of clinical trial manufacturing

With regulation changes, the death of the blockbuster, focus on personalised medicines and less R&D spend than ever before, the clinical trial manufacturing landscape has undergone many changes. SCM Pharma’s Dianne Sharp reviews the sector and outlines what companies of the future could look like
Manufacturing

SCM supports BTG in Varisolve scale-up

CDMO has previously been providing clinical development consultancy for varicose vein treatment
Subscribe now